The Use of Putative Dialysis Initiation Time in Comparative Outcomes of Patients with Advanced Chronic Kidney Disease: Methodological Aspects
DOI:
https://doi.org/10.6000/1929-6029.2022.11.16Keywords:
Chronic kidney disease, end-stage kidney disease, dialysis, linear mixed effects model, survival, propensity scoreAbstract
The latest data from the United States Renal Data Systems show over 134,000 individuals with end-stage kidney disease (ESKD) starting dialysis in the year 2019. ESKD patients on dialysis, the default treatment strategy, have high mortality and hospitalization, especially in the first year of dialysis. An alternative treatment strategy is (non-dialysis) conservative management (CM). The relative effectiveness of CM with respect to various patient outcomes, including survival, hospitalization, and health-related quality of life among others, especially in elderly ESKD or advanced chronic kidney disease patients with serious comorbidities, is an active area of research. A technical challenge inherent in comparing patient outcomes between CM and dialysis patient groups is that the start of follow-up time is “not defined” for patients on CM because they do not initiate dialysis. One solution is the use of putative dialysis initiation (PDI) time. In this work, we examine the validity of the use of PDI time to determine the start of follow-up for longitudinal retrospective and prospective cohort studies involving CM. We propose and assess the efficacy of estimating PDI time using linear mixed effects model of kidney function decline over time via simulation studies. We also illustrate how the estimated PDI time can be used to effectively estimate the survival distribution.
References
United States Renal Data System. USRDS 2021 annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from https://adr.usrds.org/2021.
Center for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. Available fromhttps://www.cdc.gov/kidneydisease/publications-resources/ ckd-national-facts.html.
United States Renal Data System. USRDS 2016 annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from https://usrds.org/previous-adrs/2010-2019/.
Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M, Grunfeld JP, Jungers P. Octogenarians reaching end-stage renal disease: Cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003; 14: 1012-1021. https://doi.org/10.1097/01.ASN.0000054493.04151.80 DOI: https://doi.org/10.1097/01.ASN.0000054493.04151.80
Alston H, Burns A. Conservative care of the patient with end-stage renal disease. Clin Med (Lond) 2015; 15(6): 567-570. https://doi.org/10.7861/clinmedicine.15-6-567 DOI: https://doi.org/10.7861/clinmedicine.15-6-567
Wachterman MW, O'Hare AM, Rahman OK, Lorenz KA, Marcantonio ER, Alicante GK, Kelley AS. One-year mortality after dialysis initiation among older adults. JAMA Intern Med 2019; 179(7): 987-990. https://doi.org/10.1001/jamainternmed.2019.0125 DOI: https://doi.org/10.1001/jamainternmed.2019.0125
Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 2013; 85: 158-165. https://doi.org/10.1038/ki.2013.252 DOI: https://doi.org/10.1038/ki.2013.252
Obi Y, Nguyen DV, Zhou H, Soohoo M, Zhang L, Chen Y, Streja E, Sim JJ, Molnar MZ, Rhee CM, Abbott KC, Jacobsen SJ, Kovesdy CP, Kalantar-Zadeh K. Development and validation of prediction scores for early mortality at transition to dialysis. Mayo Clin Proc 2018; 93(9): 1224-1235. https://doi.org/10.1016/j.mayocp.2018.04.017 DOI: https://doi.org/10.1016/j.mayocp.2018.04.017
United States Renal Data System. USRDS 2017 annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from https://usrds.org/media/2286/2017_volume_ 2_esrd_in_the_us.pdf.
Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009; 4(10): 1611-1619. https://doi.org/10.2215/CJN.00510109 DOI: https://doi.org/10.2215/CJN.00510109
Hickson LJ, Thorsteinsdottir B, Ramar P, et al. Hospital readmission among new dialysis patients associated with young age and poor functional status. Nephron 2018; 139(1): 1-12. https://doi.org/10.1159/000485985 DOI: https://doi.org/10.1159/000485985
Wetmore JB, Molony JT, Liu J, et al. Readmissions following a hospitalization for cardiovascular events in dialysis patients: a retrospective cohort study. J Am Heart Assoc 2018; 7(4). https://doi.org/10.1161/JAHA.117.007231 DOI: https://doi.org/10.1161/JAHA.117.007231
Kalantar SS, You AS, Norris KC, Nakata T, Novoa A, Juarez K, Nguyen DV, Rhee CM. The impact of race and ethnicity upon health-related quality of life and mortality in dialysis patients. Kidney Medicine 2019; 1(5): 253-262. https://doi.org/10.1016/j.xkme.2019.07.005 DOI: https://doi.org/10.1016/j.xkme.2019.07.005
Kalantar-Zadeh K, Unruh M. Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol 2005; 37(2): 367-378. https://doi.org/10.1007/s11255-004-0012-4 DOI: https://doi.org/10.1007/s11255-004-0012-4
Jassal SV, Chiu E, Hladunewich M. Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 2009; 361(16): 1612-1613. https://doi.org/10.1056/NEJMc0905289 DOI: https://doi.org/10.1056/NEJMc0905289
Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 2013; 24(3): 337-351. https://doi.org/10.1681/ASN.2012010047 DOI: https://doi.org/10.1681/ASN.2012010047
Kopple JD, Kim JC, Shapiro BB, et al. Factors affecting daily physical activity and physical performance in maintenance dialysis patients. J Ren Nutr 2015; 25(2): 217-222. https://doi.org/10.1053/j.jrn.2014.10.017 DOI: https://doi.org/10.1053/j.jrn.2014.10.017
Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009; 361(16): 1539-1547. https://doi.org/10.1056/NEJMoa0904655 DOI: https://doi.org/10.1056/NEJMoa0904655
van Loon IN, Goto NA, Boereboom FTJ, Verhaar MC, Bots ML, Hamaker ME. Quality of life after the initiation of dialysis or maximal conservative management in elderly patients: a longitudinal analysis of the Geriatric assessment in OLder patients starting Dialysis (GOLD) study. BMC Nephrol 2019; 20(1): 108. https://doi.org/10.1186/s12882-019-1268-3 DOI: https://doi.org/10.1186/s12882-019-1268-3
Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007; 22(7): 1955-1962. https://doi.org/10.1093/ndt/gfm153 DOI: https://doi.org/10.1093/ndt/gfm153
Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011; 26(5): 1608-1614. https://doi.org/10.1093/ndt/gfq630 DOI: https://doi.org/10.1093/ndt/gfq630
Hussain JA, Mooney A, Russon L. Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 2013; 27(9): 829-839. https://doi.org/10.1177/0269216313484380 DOI: https://doi.org/10.1177/0269216313484380
Verberne WR, Geers AB, Jellema WT, Vincent HH, van Delden JJ, Bos WJ. Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis. Clin J Am Soc Nephrol 2016; 11(4): 633-640. https://doi.org/10.2215/CJN.07510715 DOI: https://doi.org/10.2215/CJN.07510715
Foote C, Kotwal S, Gallagher M, Cass A, Brown M, Jardine M. Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: A systematic review and meta-analysis. Nephrology (Carlton) 2016; 21(3): 241-253. https://doi.org/10.1111/nep.12586 DOI: https://doi.org/10.1111/nep.12586
National Kidney Foundation. Estimated glomerular filtration rate, 2022. Available from https://www.kidney.org/atoz/ content/gfr.
Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007; 16(3): 241-249. https://doi.org/10.1002/pds.1357 DOI: https://doi.org/10.1002/pds.1357
Liu J, Weinhandl ED, Gilbertson DT, Collins AJ, St Peter WL. Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. Kidney Int 2012; 81(4): 341-350. https://doi.org/10.1038/ki.2011.388 DOI: https://doi.org/10.1038/ki.2011.388
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70(1): 41-55. https://doi.org/10.1093/biomet/70.1.41 DOI: https://doi.org/10.1093/biomet/70.1.41
Lu B. Propensity score matching with time-dependent covariates. Biometrics 2005; 61(3): 721-8. https://doi.org/10.1111/j.1541-0420.2005.00356.x DOI: https://doi.org/10.1111/j.1541-0420.2005.00356.x
Lenain R, Boucquemont J, Leffondré K, Couchoud C, Lassalle M, Hazzan M, Foucher Y. Clinical Trial Emulation by Matching Time-dependent Propensity Scores: The Example of Estimating Impact of Kidney Transplantation. Epidemiology 2021; 32(2): 220-229. https://doi.org/10.1097/EDE.0000000000001308 DOI: https://doi.org/10.1097/EDE.0000000000001308
Rhee CM, Nguyen DV, Nyamathi A, Kalantar-Zadeh K. Conservative vs. preservative management of chronic kidney disease: similarities and distinctions. Curr Opin Nephrol Hypertens 2020; 29(1): 92-102. https://doi.org/10.1097/MNH.0000000000000573 DOI: https://doi.org/10.1097/MNH.0000000000000573
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .